A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease (IBD) by restoring a healthier gut microbiome, according to a preliminary study by @WeillCornell investigators.
More: news.cornell.edu/index%2Ephp/st…
Learning. Discovery. Engagement. Join the Cornell conversation.

